CDK5 INHIBITOR 20-223
|
|
|
- CAS號(hào):
- 865317-30-2
- 英文名:
- CDK5 inhibitor 20-223
(CP 668863)
- 英文別名:
- CDK5 inhibitor;CDK5 inhibitor 20-223;CDK5 inhibitor 20-223
(CP 668863);2-Naphthaleneacetamide, N-(5-cyclobutyl-1H-pyrazol-3-yl)-;CDK5 inhibitor 20223,CDK5 inhibitor 20 223,CDK-5 inhibitor 20-223
- 中文名:
- CDK5 INHIBITOR 20-223
- 中文別名:
- CBNumber:
- CB04844633
- 分子式:
- C19H19N3O
- 分子量:
- 305.37
- MOL File:
- 865317-30-2.mol
|
|
|
CDK5 INHIBITOR 20-223化學(xué)性質(zhì)
-
儲(chǔ)存條件:
-
Store at -20°C
-
|
-
形態(tài):
-
Solid
-
|
-
顏色:
-
Light yellow to yellow
-
|
CDK5 INHIBITOR 20-223性質(zhì)、用途與生產(chǎn)工藝
CDK5 inhibitor 20-223 是一種有效的 CDK2 和 CDK5 抑制劑，IC50 分別為 6.0 和 8.8 nM。CDK5 inhibitor 20-223 有潛力用于結(jié)腸直腸癌 (CRC) 的研究。
|
CDK2
6.0 nM (IC
50
)
|
CDK5
8.8 nM (IC
50
)
|
CDK5 inhibitor 20-223 (10 nM-10 μM; 72 hours) potently inhibits cell growth in a panel of colorectal cancer (CRC) cell lines.
CDK5 inhibitor 20-223 (0.3125-20 μM; 6 hours) induces a dose-dependent decrease in pRB (S807/811) and pFAK (S732) levels in each of the three CRC cell lines.
Cell Viability Assay
|
Cell Line:
|
CRC cell lines SW620, DLD1, HT29, HCT116, FET, CBS, and GEO cells
|
|
Concentration:
|
10 μM, 1 μM, 100 nM, 10 nM
|
|
Incubation Time:
|
72 hours
|
|
Result:
|
Reduced cell growth. IC50s of 168±20, 480±41, 360±72, 763±92, 117±49, 568±49, 79±31 nM for SW620, DLD1, HT29, HCT116, FET, CBS, and GEO cells.
|
Western Blot Analysis
|
Cell Line:
|
CRC cell lines GEO, HCT116 and HT29
|
|
Concentration:
|
20, 10, 5, 2.5, 1.25, 0.625, 0.3125 μM
|
|
Incubation Time:
|
6 hours
|
|
Result:
|
Did not affect the total levels of CDK2/5, and the levels of total FAK or total Retinoblastoma protein (Rb).
Induced a dose-dependent decrease in pRB (S807/811) and pFAK (S732) levels.
|
CDK5 inhibitor 20-223 (8mg/kg; subcutaneously; for 14 injections) shows anti-tumor activity in human CRC xenograft tumors in nude mice.
|
Animal Model:
|
Athymic nude mice
|
|
Dosage:
|
8 mg/kg
|
|
Administration:
|
Injections were given subcutaneously daily for the first week and every other day for two more weeks for a total of 14 injections.
|
|
Result:
|
Reduced tumor growth and tumor weight in vivo.
|
CDK5 INHIBITOR 20-223
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS編號(hào) | 包裝 | 價(jià)格 |
|---|
| 2025/05/22 | HY-123772 | CDK5 inhibitor 20-223 | 865317-30-2 | 1 mg | 909元 |
| 2025/05/22 | HY-123772 | CDK5 INHIBITOR 20-223
CDK5 inhibitor 20-223 | 865317-30-2 | 5mg | 2000元 |
CDK5 INHIBITOR 20-223
生產(chǎn)廠家
865317-30-2, CDK5 INHIBITOR 20-223 相關(guān)搜索:
- 抑制劑
- 制劑-抑制劑
- 865317-30-2
- CDK5 inhibitor
- CDK5 inhibitor 20223,CDK5 inhibitor 20 223,CDK-5 inhibitor 20-223
- CDK5 inhibitor 20-223
(CP 668863)
- CDK5 inhibitor 20-223
- 2-Naphthaleneacetamide, N-(5-cyclobutyl-1H-pyrazol-3-yl)-